Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05417594
Title	Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies (CERTIS1)
Acronym	CERTIS1
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	AstraZeneca
Indications	ovarian cancer prostate cancer fallopian tube cancer peritoneum cancer high grade glioma Her2-receptor negative breast cancer pancreatic cancer
Therapies	AZD9574 AZD9574 + Temozolomide
Age Groups:	adult \| senior
Covered Countries	USA \| GBR \| ESP \| DEU \| AUS